Your browser doesn't support javascript.
loading
Spider minor ampullate silk protein nanoparticles: an effective protein delivery system capable of enhancing systemic immune responses.
Yu, Hairui; Chen, Gefei; Li, Linchao; Wei, Guoqiang; Li, Yanan; Xiong, Sidong; Qi, Xingmei.
Afiliação
  • Yu H; The Jiangsu Key Laboratory of Infection and Immunity Institutes of Biology and Medical Sciences Soochow University Suzhou China.
  • Chen G; Department of Biosciences and Nutrition Karolinska Institutet Huddinge Sweden.
  • Li L; The Jiangsu Key Laboratory of Infection and Immunity Institutes of Biology and Medical Sciences Soochow University Suzhou China.
  • Wei G; The Jiangsu Key Laboratory of Infection and Immunity Institutes of Biology and Medical Sciences Soochow University Suzhou China.
  • Li Y; Department of Neurosurgery Changhai Hospital Naval Medical University Shanghai China.
  • Xiong S; The Jiangsu Key Laboratory of Infection and Immunity Institutes of Biology and Medical Sciences Soochow University Suzhou China.
  • Qi X; The Jiangsu Key Laboratory of Infection and Immunity Institutes of Biology and Medical Sciences Soochow University Suzhou China.
MedComm (2020) ; 5(7): e573, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38882211
ABSTRACT
Spider silk proteins (spidroins) are particularly attractive due to their excellent biocompatibility. Spider can produce up to seven different types of spidroins, each with unique properties and functions. Spider minor ampullate silk protein (MiSp) might be particularly interesting for biomedical applications, as the constituent silk is mechanically strong and does not super-contract in water, attributed to its amino acid composition. In this study, we evaluate the potential of recombinant nanoparticles derived from Araneus ventricosus MiSp as a protein delivery carrier. The MiSp-based nanoparticles were able to serve as an effective delivery system, achieving nearly 100% efficiency in loading the model protein lysozyme, and displayed a sustained release profile at physiological pH. These nanoparticles could significantly improve the delivery efficacy of the model proteins through different administration routes. Furthermore, nanoparticles loaded with model protein antigen lysozyme after subcutaneous or intramuscular administration could enhance antigen-specific immune responses in mouse models, through a mechanism involving antigen-depot effects at the injection site, long-term antigen persistence, and efficient uptake by dendritic cells as well as internalization by lymph nodes. These findings highlight the transnational potential of MiSp-based nanoparticle system for protein drug and vaccine delivery.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedComm (2020) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedComm (2020) Ano de publicação: 2024 Tipo de documento: Article